Pioglitazone Hydrochloride
- Product NDC
- 72606-572
- 11-digit product format
- 726060572
- Labeler code
- 72606
- Product ID
- 72606-572_7d46fdfa-22fd-4711-a7b1-bb0aab912357
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pioglitazone Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- CELLTRION USA, INC.
- Application
- ANDA076798
- Marketing category
- ANDA
- Marketing start
- 2020-10-28
- Marketing end
- 0000-00-00
- Substance
- PIOGLITAZONE HYDROCHLORIDE
- Active strength
- 45 mg/1
- Pharmacologic classes
- Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [CS],PPAR gamma [CS],Thiazolidinedione [EPC],Thiazolidinediones [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72606-572-01 | 72606057201 | 30 TABLET in 1 BOTTLE (72606-572-01) | 30 tablet | 2020-10-28 | 0000-00-00 | No | No | Current |
| 72606-572-02 | 72606057202 | 90 TABLET in 1 BOTTLE (72606-572-02) | 90 tablet | 2020-10-28 | 0000-00-00 | No | No | Current |
| 72606-572-03 | 72606057203 | 500 TABLET in 1 BOTTLE (72606-572-03) | 500 tablet | 2020-10-28 | 0000-00-00 | No | No | Current |